Poplar Therapeutics

Cambridge, United States

Poplar Therapeutics anti-IgE therapy treats atopic diseases such as food allergy, allergic asthma, and atopic dermatitis.

$50.0M raised

Jan 2026

Series A

Health Care Medical Therapeutics

Top Investors

SR OneVida VenturesPlatanus

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Poplar Therapeutics

How much funding has Poplar Therapeutics raised?

Poplar Therapeutics has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.

Who are Poplar Therapeutics's investors?

Poplar Therapeutics's investors include SR One, Vida Ventures, Platanus.

Where is Poplar Therapeutics headquartered?

Poplar Therapeutics is headquartered in Cambridge, United States.

What does Poplar Therapeutics do?

Poplar Therapeutics anti-IgE therapy treats atopic diseases such as food allergy, allergic asthma, and atopic dermatitis.

What stage is Poplar Therapeutics at?

Poplar Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 7, 2026.

MLA

"Poplar Therapeutics — Funding & Investors." VCBacked, January 7, 2026, https://www.vcbacked.co/company/poplar-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2026). Poplar Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/poplar-therapeutics

Wikipedia (cite web)

{{cite web |title=Poplar Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/poplar-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 7, 2026.

Similar Companies in Health Care

View all

Oryl Photonics

Lausanne

Allterum Therapeutics

Circl Brain Health Metrics

Victoria$354K

YLAH

Bern$589K